Last reviewed · How we verify

NCT06825650

Investigation of the Cultural Adaptation, Validity, and Reliability of the Turkish Version of the CAP Questionnaire

Recruiting now Last updated 13 February 2025
What this trial tests

trial testing Questionnaire study in Osteoarthritis in 300 participants. Currently enrolling.

Timeline
28 November 2024
Primary endpoint
28 November 2027
28 November 2027

Quick facts

Lead sponsorHacettepe University
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment300
Start date28 November 2024
Primary completion28 November 2027
Estimated completion28 November 2027
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Hacettepe University

Who can join

18 and older, any sex, with Osteoarthritis or Back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The "CAP questionnaire," developed by modifying the CAP-Knee questionnaire to assess potential nociplastic pain features in painful musculoskeletal disorders, has been described. The "CAP questionnaire" is used in people with musculoskeletal pain and diagnostic subgroups of osteoarthritis, back pain, and fibromyalgia. There is no Turkish version of the CAP questionnaire. This study aims to investigate the cultural adaptation, validity, and reliability of the Turkish version of the "CAP questionnaire."

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Questionnaire study

Trials testing the same drug.

Other recruiting trials for Osteoarthritis

Currently open trials in the same condition.

Other Hacettepe University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06825650.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing